-
Published03/07/2025
-
Today14/07/2025
-
Deadline18/07/2025
-
Opening of tenders18/07/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Supply of medicines to NZOZ Łużyckie Centrum Medyczne w Lubaniu sp. z o.o. – Part 2 Text automatically translated in your browsing language Automatically translated
Note: Not all information for this procedure were successfully computed. Please consult linked documents for more details.
The subject of the contract are: a.supply of medicines for NZOZ Łużyckie Centrum Medyczne w Lubaniu sp. z o.o. pursuant to Part No 1, No 2, No 3, No 4, No 5, No 6, No 7, No 8, No 9, No 10, No 11, No 13, No 14, No 15, No 16, No 17 and No 18 b.supply of medicines together with lease of apparatuses/evaporators for NZOZ Łużyckie Centrum Medyczne w Lubaniu sp. z o.o. pursuant to Part No 12. The contracting authority shall allow partial tenders to be submitted. The Ordering Party shall consider as a partial offer an offer submitted for all items in a given part. Total number of lots in the present proceedings: 18. A detailed description of the subject-matter of the contract together with the specification of the assortment falling within the scope of the subject-matter of the contract can be found in the Assortment and Price Form, constituting Annex No. 3 to the FTZ. The contracting authority does not allow the submission of partial tenders for individual items within a given lot. The contracting authority requires that the offered subject of the contract: 1) as regards Parts 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12 (item No 1), 13, 14 (except item No 3, No 9, No 127, No 131, No 143, No 192, No 215, No 216, No 268, No 295, No 426, No 429, No 452, No 455), 16, 17 (except item No 11) – it was registered as a medicine and complied with the requirements of the Pharmaceutical Law of 6 September 2001 (Journal of Laws 2024.686, i.e. of 2024.05.06), 2) as regards Part 12 (item No 2, No 3, No 4) No 14 (item No 3, No 9, No 127, No 131, No 192, No 295, No 429), 15, 17 (item No 11) – it was registered as a medical device and complied with the requirements of the Medical Devices Act of 7 April 2022 (Journal of Laws 2024.1620 of 2024.11.05) and Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices (Medical Devices Regulation) and had legally required registration certificates, attestations, certificates and other documents allowing the subject of the contract to be placed on the market and used in Poland. 3) with regard to Parts 5, 14 (item No 143, No 215, No 216, No 268, No 452), a foodstuff intended for particular nutritional uses met the requirements of the Regulation of the Minister of Health of 16 September 2010 on foodstuffs intended for particular nutritional uses (Journal of Laws 2015.1026, i.e. of 2015.07.23). Text automatically translated in your browsing language Automatically translated
https://www.platformazakupowa.pl/transakcja/1120114
https://www.platformazakupowa.pl/transakcja/1120114
33600000 - Pharmaceutical products
33651500 - Immune sera and immunoglobulins
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33640000 - Medicinal products for the genitourinary system and hormones
33660000 - Medicinal products for the nervous system and sensory organs
33610000 - Medicinal products for the alimentary tract and metabolism
33692200 - Parenteral nutrition products
33690000 - Various medicinal products
33651100 - Antibacterials for systemic use
33140000 - Medical consumables CVP code deduced from the text of the procedure AI-generated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.